Delcath Systems Inc (DCTH)

[Looking4BIGcash]

It's just short term Trading. The big thing to watch here is how different this company is from just 60 days ago. Debt gone, float has been cleaned up 350-1, REV in Europe, new Director:

Simon Pedder, Ph.D.
Director

Simon Pedder, Ph.D. Dr. Pedder joined the Delcath Board of Directors in November 2017. Dr. Pedder is a scientist and pharmaceutical executive with a 30-year career in drug development. He currently serves as Chief Business and Strategy Officer at Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. During his long career in drug development, Dr. Pedder has held several leadership positions including President and CEO of Cellectar Biosciences, President and CEO of Chelsea Therapeutics, Executive Officer and Vice President of Oncology Pharma Business at Hoffmann-LaRoche, Life Cycle Leader and Global Project Leader of Pegasys/IFN and Head of the Hepatitis Franchise at Hoffmann-LaRoche. Dr. Pedder led the late stage development and commercial launch of multiple proprietary pharmaceutical products, including Pegasys®, Copegus® and Northera®.


It will be fun to see the Shorts scramble when the next PR drops.
Pigs get fed, Hogs get slaughtered.

I still see a buyout here... time will tell.